The endocannabinoid system: a potential target for the treatment of various diseases
H Lowe, N Toyang, B Steele, J Bryant… - International journal of …, 2021 - mdpi.com
The Endocannabinoid System (ECS) is primarily responsible for maintaining homeostasis, a
balance in internal environment (temperature, mood, and immune system) and energy input …
balance in internal environment (temperature, mood, and immune system) and energy input …
A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars
A Stella, B Palmieri, C Laurino… - La Clinica Terapeutica, 2019 - clinicaterapeutica.it
Objective To investigate the therapeutic effect of CBD-ointment administered on severe skin
chronic diseases and/or on their outcome scars. Methods A spontaneous, anecdotal …
chronic diseases and/or on their outcome scars. Methods A spontaneous, anecdotal …
Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system
S Zou, U Kumar - International journal of molecular sciences, 2018 - mdpi.com
The biological effects of cannabinoids, the major constituents of the ancient medicinal plant
Cannabis sativa (marijuana) are mediated by two members of the G-protein coupled …
Cannabis sativa (marijuana) are mediated by two members of the G-protein coupled …
[HTML][HTML] Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Abstract N-acylethanolamines (NAEs), including N-palmitoylethanolamine (PEA), N-
oleoylethanolamine (OEA), N-arachidonoylethanolamine (AEA, anandamide), N …
oleoylethanolamine (OEA), N-arachidonoylethanolamine (AEA, anandamide), N …
Structural basis of selective cannabinoid CB2 receptor activation
X Li, H Chang, J Bouma, LV de Paus… - Nature …, 2023 - nature.com
Abstract Cannabinoid CB2 receptor (CB2R) agonists are investigated as therapeutic agents
in the clinic. However, their molecular mode-of-action is not fully understood. Here, we report …
in the clinic. However, their molecular mode-of-action is not fully understood. Here, we report …
Phytocannabinoids: a unified critical inventory
Covering up to January 2016 Cannabis sativa L. is a prolific, but not exclusive, producer of a
diverse group of isoprenylated resorcinyl polyketides collectively known as …
diverse group of isoprenylated resorcinyl polyketides collectively known as …
[HTML][HTML] Medicinal cannabis: history, pharmacology, and implications for the acute care setting
MB Bridgeman, DT Abazia - Pharmacy and therapeutics, 2017 - ncbi.nlm.nih.gov
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
[HTML][HTML] Cannabinoids and pain: new insights from old molecules
S Vučković, D Srebro, KS Vujović, Č Vučetić… - Frontiers in …, 2018 - frontiersin.org
Cannabis has been used for medicinal purposes for thousands of years. The prohibition of
cannabis in the middle of the 20th century has arrested cannabis research. In recent years …
cannabis in the middle of the 20th century has arrested cannabis research. In recent years …
[HTML][HTML] Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Epidemiological studies reveal that marijuana increases the risk of cardiovascular disease
(CVD); however, little is known about the mechanism. Δ 9-tetrahydrocannabinol (Δ 9-THC) …
(CVD); however, little is known about the mechanism. Δ 9-tetrahydrocannabinol (Δ 9-THC) …
Molecular targets of the phytocannabinoids: a complex picture
P Morales, DP Hurst, PH Reggio - Phytocannabinoids: Unraveling the …, 2017 - Springer
For centuries, hashish and marihuana, both derived from the Indian hemp Cannabis sativa
L., have been used for their medicinal, as well as, their psychotropic effects. These effects …
L., have been used for their medicinal, as well as, their psychotropic effects. These effects …